Gene: PPP1R37
Official Full Name: protein phosphatase 1 regulatory subunit 37provided by HGNC
Gene Summary: Predicted to enable protein phosphatase inhibitor activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14930 | PPP1R37 Knockout cell line (HeLa) | Human | PPP1R37 | 1:3~1:6 | Negative | Online Inquiry |
KO14931 | PPP1R37 Knockout cell line (HCT 116) | Human | PPP1R37 | 1:2~1:4 | Negative | Online Inquiry |
KO14932 | PPP1R37 Knockout cell line (HEK293) | Human | PPP1R37 | 1:3~1:6 | Negative | Online Inquiry |
KO14933 | PPP1R37 Knockout cell line (A549) | Human | PPP1R37 | 1:3~1:4 | Negative | Online Inquiry |
PPP1R37 Gene Knockout Cell Lines are specialized in vitro tools designed to facilitate the study of the protein phosphatase 1 regulatory subunit 37 (PPP1R37) gene’s function and its implications in various biological processes. By employing state-of-the-art CRISPR-Cas9 gene editing technology, these cell lines have been meticulously engineered to silence the expression of the PPP1R37 gene, allowing researchers to explore the resulting phenotypic effects and molecular mechanisms in a controlled environment.
The key function of the PPP1R37 Gene Knockout Cell Lines is to provide a reliable model for investigating the role of PPP1R37 in cellular processes such as cell proliferation, apoptosis, and signal transduction pathways. Through the complete knockdown of this gene, users can assess the downstream effects on protein interactions and metabolic pathways, significantly contributing to our understanding of diseases where PPP1R37 is implicated, such as cancer and neurodegenerative disorders.
In terms of scientific importance, these cell lines serve as valuable tools in both basic research and drug development. Researchers can utilize them in high-throughput screening assays to identify potential therapeutic agents that target cellular pathways associated with altered PPP1R37 expression. Their applicability extends to preclinical studies where understanding the gene’s role in disease mechanisms is pivotal for developing innovative treatment strategies.
What sets our PPP1R37 Gene Knockout Cell Lines apart from alternatives is their superior quality control and the comprehensive characterization of the knockout status, ensuring reproducibility and reliability in experimental outcomes. These cell lines come with extensive documentation and support, empowering researchers to seamlessly integrate them into their investigations.
The value of PPP1R37 Gene Knockout Cell Lines lies in their ability to uncover biological insights that can lead to novel therapeutic advancements, making them an indispensable resource for researchers and clinicians alike who are committed to pushing the boundaries of scientific understanding.
At [Company Name], we pride ourselves on our expertise in providing high-quality biological products that meet the evolving needs of the research community. Our commitment to excellence ensures that you receive not only cutting-edge tools but also the support necessary to drive innovation in your field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.